Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Transdermal Drug Delivery Systems Market, by region, 2020-2030 (USD Billion)
1.2.2. Transdermal Drug Delivery Systems Market, by Technology, 2020-2030 (USD Billion)
1.2.3. Transdermal Drug Delivery Systems Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Transdermal Drug Delivery Systems Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Transdermal Drug Delivery Systems Market Dynamics
3.1. Transdermal Drug Delivery Systems Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of chronic diseases
3.1.1.2. Growing geriatric population
3.1.1.3. Government initiatives promoting the development and use of transdermal drug delivery systems
3.1.2. Market Challenges
3.1.2.1. High Cost of Transdermal Drug Delivery Systems
3.1.2.2. Regulatory Challenges
3.1.3. Market Opportunities
3.1.3.1. Ongoing research and development activities
3.1.3.2. Rising investment in healthcare industry
Chapter 4. Global Transdermal Drug Delivery Systems Market: Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Transdermal Drug Delivery Systems Market, by Technology
5.1. Market Snapshot
5.2. Global Transdermal Drug Delivery Systems Market by Technology, Performance - Potential Analysis
5.3. Global Transdermal Drug Delivery Systems Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
5.4. Transdermal Drug Delivery Systems Market, Sub Segment Analysis
5.4.1. Electroporation
5.4.2. Radio Frequency
5.4.3. Iontophoresis
5.4.4. Microporation
5.4.5. Thermal
5.4.6. Mechanical arrays
5.4.7. Ultrasound
5.4.8. Others
Chapter 6. Global Transdermal Drug Delivery Systems Market, by Application
6.1. Market Snapshot
6.2. Global Transdermal Drug Delivery Systems Market by Application, Performance - Potential Analysis
6.3. Global Transdermal Drug Delivery Systems Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Transdermal Drug Delivery Systems Market, Sub Segment Analysis
6.4.1. CNS
6.4.2. Pain Management
6.4.3. Cardiovascular
6.4.4. Hormone
6.4.5. Immunological
6.4.6. Metabolic
6.4.7. Gastrointestinal
6.4.8. Infection
6.4.9. Cancer
6.4.10. Others
Chapter 7. Global Transdermal Drug Delivery Systems Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Transdermal Drug Delivery Systems Market, Regional Market Snapshot
7.4. North America Transdermal Drug Delivery Systems Market
7.4.1. U.S. Transdermal Drug Delivery Systems Market
7.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Transdermal Drug Delivery Systems Market
7.5. Europe Transdermal Drug Delivery Systems Market Snapshot
7.5.1. U.K. Transdermal Drug Delivery Systems Market
7.5.2. Germany Transdermal Drug Delivery Systems Market
7.5.3. France Transdermal Drug Delivery Systems Market
7.5.4. Spain Transdermal Drug Delivery Systems Market
7.5.5. Italy Transdermal Drug Delivery Systems Market
7.5.6. Rest of Europe Transdermal Drug Delivery Systems Market
7.6. Asia-Pacific Transdermal Drug Delivery Systems Market Snapshot
7.6.1. China Transdermal Drug Delivery Systems Market
7.6.2. India Transdermal Drug Delivery Systems Market
7.6.3. Japan Transdermal Drug Delivery Systems Market
7.6.4. Australia Transdermal Drug Delivery Systems Market
7.6.5. South Korea Transdermal Drug Delivery Systems Market
7.6.6. Rest of Asia Pacific Transdermal Drug Delivery Systems Market
7.7. Latin America Transdermal Drug Delivery Systems Market Snapshot
7.7.1. Brazil Transdermal Drug Delivery Systems Market
7.7.2. Mexico Transdermal Drug Delivery Systems Market
7.8. Middle East & Africa Transdermal Drug Delivery Systems Market
7.8.1. Saudi Arabia Transdermal Drug Delivery Systems Market
7.8.2. South Africa Transdermal Drug Delivery Systems Market
7.8.3. Rest of Middle East & Africa Transdermal Drug Delivery Systems Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Novartis AG
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Johnson & Johnson
8.3.3. Mylan Pharmaceuticals, Inc.
8.3.4. Boehringer Ingelheim GmbH
8.3.5. Hisamitsu Pharmaceutical co. Inc
8.3.6. 3M Company
8.3.7. Noven Pharmaceuticals, Inc.
8.3.8. 4P Therapeutics, LLC
8.3.9. Grunenthal GmbH
8.3.10. AbbVie Inc
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption